Norris P.G., Morris J., McGibbon D.M., Chu A.C., Hawk J.L. Polymorphic light eruption: an immunopathological study of evolving lesions. Br J Dermatol 1989; 120(2):173-183.
van de Pas C.B., Kelly D.A., Seed P.T. et al. Ultraviolet-radiation-induced erythema and suppression of contact hypersensitivity responses in patients with polymorphic light eruption. J. Invest. Dermatol. 2004; 122(2):295-299.
Palmer R.A., Friedmann P.S. Ultraviolet radiation causes less immunosuppression in patients with polymorphic light eruption than in controls. J Invest Dermatol. 2004; 122(2):291-294.
Jansén C.T. Heredity of chronic polymorphous light eruptions. Arch Dermatol. 1978; 114(2):188-190.
McGregor J.M., Grabczynska S., Vaughan R., et al. Genetic modeling of abnormal photosensitivity in families with polymorphic light eruption and actinic prurigo. J. Invest. Dermatol. 2000;115:471 6.
Morison W.L., Stern R.S. Polymorphous light eruption: a common reaction uncommonly recognized. Acta Derm. Venereol. 1982; 62(3): 237-240.
Ros A., Wennersten G. Current aspects of polymorphous light eruptions in Sweden. Photodermatol. 1986; 3(5): 298-302.
Pao C., Norris P.G., Corbett M., Hawk J.L. Polymorphic light eruption: prevalence in Australia and England. Br. J. Dermatol. 1994;130(1): 62-64.
Rhodes L.E., Bock M., Janssens A.S. et al. Polymorphic light eruption occurs in 18% of Europeans and does not show higher prevalence with increasing latitude: multicenter survey of 6,895 individuals residing from the Mediterranean to Scandinavia. J. Invest. Dermatol. 2010; 130(2): 626-628.
Horkay I, Emri G, Varga V, Simics E, Remenyik E. Photosensitivity skin disorders in childhood. Photodermatol. Photoimmunol. Photomed. 2008; 24: 56 60.
Jansén CT. Heredity of chronic polymorphous light eruptions. Arch. Dermatol. 1978; 114: 188 190.
Lehmann P. Diagnostic approach to photodermatoses. J. Dtsch. Dermatol. Ges. 2006; 4(11):965-975.
De Argila D., Aguilera J., Sánchez J., García-Díez A. Study of idiopathic, exogenous photodermatoses, part II: photobiologic testing. Actas Dermosifiliogr. 2014; 105(3):233-242.
Grossberg A. L. Pediatric photosensitivity. Photodermatology. Photoimmunology. Photomedicine. 2012, 28, 174 180.
Blakely K. M., Drucker, A., Rosen, C. Drug-Induced Photosensitivity—An Update: Culprit Drugs, Prevention and Management. Drug Safety. 2019(42)7: 827 847.
Inamadar AC, Palit A. Photosensitivity in children: an approach to diagnosis and management. Indian J. Dermatol.Venereol. Leprol. 2005; 71: 73 79.
Horkay I, Bodolay E, Krajczar J, et al. In situ identification of T lymphocytes in polymorphic light eruption. Photodermatology 1984;1:250 2.
Bylaite M., Grigaitiene J. and. Lapinskaite G.S. Photodermatoses: classification, evaluation and management. British Journal of Dermatology 2009; 161(3):61 68.
Schleyer V., Weber O., Yazdi A. et al. Prevention of polymorphic light eruption with a sunscreen of very high protection level against UVB and UVA radiation under standardized photodiagnostic conditions. Acta Derm .Venereol. 2008;88:555 60.
Azurdia R.M., Pagliaro J.A., Rhodes L.E. Sunscreen application technique in photosensitive patients: a quantitative assessment of the effect of education. Photodermatol. Photoimmunol. Photomed. 2000;16:53 60.
Ortel B., Tanew A., Wolff K., Hönigsmann H. Polymorphous light eruption: action spectrum and photoprotection. J Am Acad Dermatol 1986; 14(5 Pt 1):748-753.
Boonstra H.E., van Weelden H., Toonstra J., van Vloten W.A. Polymorphous light eruption: a clinical, photobiologic, and follow-up study of 110 patients. J. Am. Acad. Dermatol. 2000; 42(2 Pt 1):199-207.
Patel D.C., Bellaney G.J., Seed P.T., McGregor J.M., Hawk J.L. Efficacy of short-course oral prednisolone in polymorphic light eruption: a randomized controlled trial. Br J Dermatol 2000; 143(4): 828-831.
Eberlein-König B., Fesq H., Abeck D., Przybilla B., Placzek M., Ring J. Systemic vitamin C and vitamin E do not prevent photoprovocation test reactions in polymorphous light eruption. Photodermatol. Photoimmunol. Photomed. 2000;16(2): 50-52.
Shipley D.R., Hewitt J.B. Polymorphic light eruption treated with cyclosporin. Br .J. Dermatol .2001; 144(2): 446-447.
Lasa O., Trebol I., Gardeazabal J., Diaz-Perez J.L. Prophylactic short-term use of cyclosporin in refractory polymorphic light eruption. J. Eur. Acad. Dermatol .Venereol. 2004; 18(6): 747-748.
Hadshiew I.M., Treder-Conrad C., v Bülow R. et al. Polymorphous light eruption (PLE) and a new potent antioxidant and UVA-protective formulation as prophylaxis. Photodermatol. Photoimmunol. Photomed. 2004; 20(4) :200-204.
Bilsland D., George S.A., Gibbs N.K., Aitchison T., Johnson B.E., Ferguson J. A comparison of narrow band phototherapy (TL-01) and photochemotherapy (PUVA) in the management of polymorphic light eruption. Br. J. Dermatol. 1993; 129(6): 708-712.
Man I., Dawe R.S., Ferguson J. Artificial hardening for polymorphic light eruption: practical points from ten years" experience. Photodermatol .Photoimmunol. Photomed. 1999; 15(3-4): 96-99.
Murphy G.M., Logan R.A., Lovell C.R. et al. Prophylactic PUVA and UVB therapy in polymorphic light eruption - a controlled trial. Br. J. Dermatol. 1987; 116(4): 531-538.
Addo HA, Sharma SC. UVB phototherapy and photochemotherapy (PUVA) in the treatment of polymorphic light eruption and solar urticaria. Br. J. Dermatol. 1987; 116(4):539-547.
Franken S.M., Genders R.E., de Gruijl F.R., Rustemeyer T., Pavel S. Skin hardening effect in patients with polymorphic light eruption: comparison of UVB hardening in hospital with a novel home UV-hardening device. J. Eur. Acad. Dermatol. Venereol. 2013; 27(1): 67-72.
Leonard F., Morel M., Kalis B. et al. Psoralen plus ultraviolet A in the prophylactic treatment of benign summer light eruption. Photodermatol. Photoimmunol. Photomed. 1991; 8(3): 95-98.